End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.81 CNY | -0.35% | -0.03% | -11.79% |
Apr. 08 | Shenzhen Xintai Pharmaceutical's Drug to Treat Chronic Heart Failure Set for Clinical Trials | MT |
Mar. 26 | Salubris Pharma's Profit, Revenue Slip in 2023 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.79% | 4.34B | |
+20.91% | 43.54B | |
+16.96% | 21.74B | |
+7.98% | 13.02B | |
+6.69% | 13.53B | |
+33.80% | 11.28B | |
-11.05% | 6.99B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+7.71% | 5.09B |
- Stock Market
- Equities
- 002294 Stock
- News Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Tranche Update on Shenzhen Salubris Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on October 8, 2019.